Maria Sharapova faces a major hurdle in her tennis career after failing the dope test. Sharapova’s career is hanging by a thread because of her failed test.
According to People, the tennis star’s career is on the verge of downfall during the Australian Open preparations. One of the requirements for the event is to pass the drug test. Sharapova failed to meet the criteria, disqualifying her to showcase her skills on the court.
The test was strictly set to ensure that each athlete is physically fit and able to play the game with pure endurance and strength. More detailed information published by CNN showed that the tennis player was positively using Meldonium.
On a different note, Sharapova rebutted that she had been given this medicine, which is also called Mildronate for the past ten years by their family doctor. It is a drug utilized to assist an athlete in gaining strength, stamina and remedy.
Furthermore, the said medication was not banned for many years; the ban was only initiated January 1 of this year. To prove the latter, Sharapova stated, “It’s very important for you to understand for 10 years this medicine was not on WADA’s banned list and I had been legally taking the medicine for the past 10 years. But on January 1, the rules had changed and Meldonium became a prohibited substance, which I had not known.”
Her track record in playing professional tennis is something to ponder upon. Indeed, her skills and expertise have made her reach this far. As for the consequences, it was then revealed by The International Tennis Federation that Maria Sharapova will face suspension that will take effect on March 12. Given that it is a full suspension, Sharapova will bag the title of being the highest profile tennis player sanctioned.
Looking back, Maria Sharapova is one of the best tennis players of all time. She was able to amass numerous achievements including being a five-time Grand Slam champion as well as being the former world No. 1 in singles.
Photo Source: Maria Sharapova/ Facebook